Drug-Induced Sarcoid-like Reactions Associated to Targeted Therapies and Biologic Agents

QR Code

Drug-Induced Sarcoid-like Reactions Associated to Targeted Therapies and Biologic Agents

<b>Background</b>: Sarcoidosis is a multisystem inflammatory disease characterized by the immune-mediated formation of non-necrotizing epithelioid granulomas. Several commonly used medications can induce similar granulomatous reactions, known as drug-induced sarcoid-like reactions (DISRs...

Full description

Saved in:

Bibliographic Details
Main Authors:	Federica Andolfi, Luca Caffarri, Matilde Neviani, Silvia Rubini, Dario Andrisani, Filippo Gozzi, Bianca Beghé, Enrico Clini, Roberto Tonelli, Stefania Cerri
Format:	Article
Language:	English
Published:	MDPI AG 2025-06-01
Series:	Diagnostics
Subjects:	sarcoidosis drug-induced sarcoid like reactions immune checkpoint inhibitors TNF-α antagonists BRAF inhibitors monoclonal antibodies
Online Access:	https://www.mdpi.com/2075-4418/15/13/1658
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Splenic sarcoid reaction mimicking metastases in patients after uterine cancer surgery: a report of two cases
by: Kei Kitamura, et al.
Published: (2023-09-01)

Hepatocellular carcinoma with regional lymphadenopathy caused by sarcoid-like reaction: a case report
by: Tomoko Mizota, et al.
Published: (2021-03-01)

Necrotic sarcoid granulomatosis – a late stage of nodular sarcoidosis or an independent disease? Analysis of a clinical case
by: E. A. Galushko, et al.
Published: (2023-10-01)

Esophageal cancer associated with a sarcoid-like reaction and systemic sarcoidosis in lymph nodes: supportive findings of [18F]-fluorodeoxyglucose positron emission tomography–computed tomography during neoadjuvant therapy
by: Takayoshi Kishino, et al.
Published: (2018-06-01)

Sarcoid-like reaction at the patient with chronic hepatitis C on a background of antiviral therapy
by: A. V. Lapshin, et al.
Published: (2010-06-01)

Splenic sarcoid reaction mimicking metachronous metastasis in patients after distal gastrectomy for gastric cancer: a case report and literature review
by: Haruhiko Okada, et al.
Published: (2020-07-01)

Will we have a new ending for Irvin Yalom's novel? A medical oncologist view
by: Nalan Akgül Babacan
Published: (2016-04-01)

A Delayed Presentation of Immune Checkpoint Inhibitor Colitis
by: Alicia Nahhas, et al.
Published: (2025-06-01)

Immune checkpoint inhibitor myocarditis: a systematic case study
by: E. A. Kushnareva, et al.
Published: (2020-12-01)

Negative Immune Checkpoint Inhibitors
by: Magda Drewniak-Świtalska, et al.
Published: (2025-05-01)

Resistance to immune checkpoint inhibitors in the treatment of metastatic renal cancer
by: A. A. Izmailov, et al.
Published: (2023-09-01)

Clinical and Radiographic Features of Lymphogenous Dissemination in Pulmonary Tuberculosis
by: A. S. Vinokurov, et al.
Published: (2020-09-01)

Targeted therapy of anaplastic thyroid cancer
by: P. A. Nikiforovich, et al.
Published: (2023-03-01)

Combination of rheumatoid arthritis and sarcoidosis, which had occurred during rituximab therapy, complicated secondary immunodeficiency and intolerance to the main basic drugs: Case repost and literature review
by: O. A. Golovina, et al.
Published: (2021-10-01)

Case Report: Tislelizumab-induced insulin-dependent diabetes mellitus: a case report and literature review
by: Panpan Ji, et al.
Published: (2025-07-01)

Treatment Outcomes of Systemic Therapies for Infiltrative Hepatocellular Carcinoma
by: Chen PY, et al.
Published: (2025-06-01)

The role of immunotherapy in the treatment of skin melanoma: a contemporary perspective
by: P. S. Masaeva
Published: (2024-06-01)

Nivolumab in combination with radiotherapy for metastatic esophageal neuroendocrine carcinoma after esophagectomy: a case report
by: Kuniyasu Takagi, et al.
Published: (2021-10-01)

Cancer Immunotherapy: The Role of Nursing in Patient Education, Assessment, Monitoring, and Support
by: Parmis Mirzadeh, et al.
Published: (2025-07-01)

Predictors of Long‐Term Survival in Patients With Immune Checkpoint Inhibitor–Associated Myocarditis
by: Nikhil Dubey, et al.
Published: (2025-07-01)

The Higher Incidence of Liver Injury in HCC Patients Compared to Other Malignancies During Immune-Checkpoint Inhibitor Therapy is Primarily Due to Tumor Progression
by: Wang Y, et al.
Published: (2025-06-01)

Atherosclerosis and Inflammation: Are the Rules of the Game Changing with Biological Therapies?
by: Bora R, et al.
Published: (2025-07-01)

Interdisciplinary approach to the management of patients with uterine cancer progression
by: K. Yu. Morkhov, et al.
Published: (2022-05-01)

Development and pharmacokinetic assessment of a fully canine anti-PD-1 monoclonal antibody for comparative translational research in dogs with spontaneous tumors
by: Sho Yoshimoto, et al.
Published: (2023-12-01)

CERTOLIZUMAB PEGOL IN THE TREATMENT OF TAKAYASU ARTERITIS: THE FIRST EXPERIENCE AND PROSPECTS
by: P. I. Novikov, et al.
Published: (2018-07-01)

A Rare Hypersensitivity Reaction with Golimumab: Recurrent Fever After Each Injection
by: Berna Günay, et al.
Published: (2025-08-01)

Immunotherapy in patients with cervical cancer
by: A. G. Kedrova
Published: (2020-11-01)

Drug-associated abdominal aortitis and retroperitoneal fibrosis after treatment with nivolumab
by: Naomi Wedel, MD, BSc, et al.
Published: (2025-08-01)

Complete Blood Count-Derived Biomarkers’ Association with Risk of PD-1 or PD-1/CTLA-4 Inhibitor-Induced Hypothyroidism in Patients with Solid Tumors
by: Ketevan Lomidze, et al.
Published: (2025-06-01)

Pathological complete response after afatinib treatment of stage IV oligometastatic adenocarcinoma of the lung: the role of pulmonary surgery
by: Ping-Chung Tsai, et al.
Published: (2019-11-01)

Risk Factors Associated with the Development of Immune-Checkpoint Inhibitor Diabetes Mellitus: An Integrative Review
by: Vivian Crowder, et al.
Published: (2025-07-01)

COMBINED ANTIHYPERTENSIVE THERAPY: ACE INHIBITOR PLUS CALCIUM CHANNEL BLOCKER. NEW ADVANTAGES OF THE KNOWN COMBINATION
by: S. A. Boitsov, et al.
Published: (2016-01-01)

Immunohistochemical Profiling of Immune Checkpoints in Chronic Hepatitis B Liver Tissue
by: João Panão-Costa, et al.
Published: (2025-06-01)

Adding dendritic cell-immunotherapy for post-transplant hepatocellular carcinoma recurrence
by: Wei-Chen Lee, et al.
Published: (2025-08-01)

Combined radiation and immune checkpoint inhibitor therapy for metastatic or recurrent hepatocellular carcinoma: a real-world study of 108 patients
by: Yirui Zhai, et al.
Published: (2025-08-01)

Can Janus kinase inhibitors be used to treat immune checkpoint inhibitor associated adverse events?
by: Jürgen Braun, et al.
Published: (2024-11-01)

Case Report: Immune checkpoint inhibitor exhibits dual benefits for a refractory lymphoma patient with disseminated mucormycosis
by: Qibei Teng, et al.
Published: (2025-07-01)

Real-world Evidence from a Retrospective Multicentre Analysis on First-line Therapy for Metastatic Papillary Renal Cell Carcinoma. A GUARDIANS Project
by: Thomas Hilser, et al.
Published: (2025-08-01)

The administration of PD-1 and PD-L1 inhibitors in pediatric hematology: a literature review
by: Aleksandra S. Paderina, et al.
Published: (2024-07-01)

Evaluation of cardiovascular comorbidity in cancer patients and analysis of potential risk factors for cardiovascular complications of checkpoint inhibitor therapy
by: E. A. Kushnareva, et al.
Published: (2022-01-01)